Clinical Trials Directory

Trials / Completed

CompletedNCT02818361

Topical Tripterygium Wilfordii Gel for Moderate Activity Rheumatoid Arthritis

Topical Tripterygium Wilfordii Gel for Treatment in Patients With Moderate Activity Rheumatoid Arthritis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Tripterygium wilfordii Hook F (TwHF), a traditional Chinese herb, is widely used in China for treating Rheumatoid Arthritis (RA), but limited only for elderly RA patients because of its reproductive system toxicity. The investigators are inspired by Chinese external therapy, an immemorial therapy for thousands of years, and take its advantage to make TwHF topically in order to get an effective and safe treatment for active RA patients.

Conditions

Interventions

TypeNameDescription
DRUGTopical tripterygium gel
DRUGPlacebo gel

Timeline

Start date
2012-04-01
Primary completion
2013-03-01
Completion
2013-12-01
First posted
2016-06-29
Last updated
2018-11-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02818361. Inclusion in this directory is not an endorsement.